By integrating multiple in vitro assays, including cell viability, migration, flow cytometry, western blotting, and fluorescence microscopy, this research provides a comprehensive mechanistic evaluation of NAR's therapeutic potential in breast cancer. The gene discussed is CPSF4; the disease is breast cancer.